“Safety of subcutaneous immunotherapy with tyrosine-adsorbed house dust mite extracts in patients with allergic disease”, Rev Alerg Mex, vol. 64, no. 1, pp. 52–65, Feb. 2017, doi: 10.29262/ram.v64i1.233.